Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Accumulated Expenses (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Accumulated Expenses for 9 consecutive years, with $59.5 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 19.42% to $59.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $59.5 million through Dec 2025, up 19.42% year-over-year, with the annual reading at $59.5 million for FY2025, 19.42% up from the prior year.
  • Accumulated Expenses hit $59.5 million in Q4 2025 for Inspire Medical Systems, up from $51.6 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $59.5 million in Q4 2025 to a low of $10.4 million in Q1 2021.
  • Historically, Accumulated Expenses has averaged $30.6 million across 5 years, with a median of $29.5 million in 2022.
  • Biggest YoY gain for Accumulated Expenses was 68.32% in 2023; the steepest drop was 3.37% in 2023.
  • Year by year, Accumulated Expenses stood at $20.5 million in 2021, then skyrocketed by 67.88% to $34.3 million in 2022, then rose by 14.35% to $39.3 million in 2023, then rose by 26.86% to $49.8 million in 2024, then rose by 19.42% to $59.5 million in 2025.
  • Business Quant data shows Accumulated Expenses for INSP at $59.5 million in Q4 2025, $51.6 million in Q3 2025, and $40.2 million in Q2 2025.